[Treatment of patients with advanced ovarian cancer at the Gynecological Clinic of Pécs Medical University].
Treatment protocols for advanced ovarian tumors (stages III-IV), applied at the author's institute, are presented. Giving a short survey the outcome with single agent cyclophosphamide therapy (C; n = 82), combinations without cisplatin (CMV, CAV; n = 83) or combination with cisplatin (CAP; n = 41) has been compared. A significant difference between C and CMV/CAV groups could be found only in regards with remission period (p = 0.0004 and 0.0001). By the use of CAP the result became better not only in the extent and the duration of remission but in the survival as well as compared to that of the other groups. The importance of the extent of residual tumor is emphasized. Because of serious side effects of particularly cisplatin based, three drug combinations the use of combinations consisting of two drugs only can be recommended in accordance with literary data. By the estimation of the usefulness of second look operation's findings the radiotherapy with its consolidationary effect and also the significance of a maintaining or a second line cytostatic treatment are pointed out.
Krommer
K
K
Pécsi Orvostudományi Egyetem Szülészeti.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006814:Hungary; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide
Elörehaladott petefészekrákos betegek kezelése a Pécsi Orvostudományi Egyetem Nöi Klinikáján.